Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
FTREFortrea Holdings	$2.14bn	n/a	n/a
BEAMBeam Therapeutics	$2.05bn	n/a	n/a
KYMRKymera Therapeutics	$2.04bn	n/a	n/a
NVAXNovavax	$2.02bn	n/a	n/a
GRALVGrail	$1.99bn	n/a	n/a
RCKTRocket Pharmaceuticals	$1.98bn	n/a	n/a
VERAVera Therapeutics	$1.97bn	n/a	n/a
PTGXProtagonist Therapeutics	$1.96bn	13.58	n/a
MRVIMaravai Lifesciences Holdings	$1.89bn	n/a	n/a
BLUBELLUS Health	CA$2.47bn	n/a	n/a
FUSNFusion Pharmaceuticals	$1.83bn	n/a	n/a
INBXInhibrx	$1.79bn	n/a	n/a
KROSKeros Therapeutics	$1.78bn	n/a	n/a
AMAMAmbrx Biopharma	$1.76bn	n/a	n/a
ARVNArvinas	$1.76bn	n/a	n/a
NAMSNewAmsterdam Pharma NV	$1.73bn	n/a	n/a
SNDXSyndax Pharmaceuticals	$1.71bn	n/a	n/a
AKROAkero Therapeutics	$1.66bn	n/a	n/a
EWTXEdgewise Therapeutics	$1.63bn	n/a	n/a
VCYTVeracyte	$1.60bn	n/a	n/a